Key takeaways
Syphilis, caused by the bacterium Treponema pallidum, can affect the eyes at any stage. Ocular involvement ranges from mild surface inflammation to sight-threatening conditions. Common manifestations include uveitis, iridocyclitis, chorioretinitis, optic neuritis, and anterior uveitis. Early detection and prompt treatment with appropriate antibiotics, typically penicillin, can reduce the risk of permanent vision loss. This overview explains how syphilis affects the eye, symptoms to watch for, diagnostic steps, and treatment options.
What is syphilis?
Syphilis is a sexually transmitted infection caused by Treponema pallidum. It progresses through distinct stages—primary, secondary, latent, and tertiary—each with different signs and potential complications. Ocular syphilis refers to eye involvement due to active infection or immune responses to the bacteria. Eye involvement can occur in early or late disease and may affect any part of the eye, including the conjunctiva, uvea, retina, and optic nerve.
How does syphilis affect the eyes?
Ocular syphilis includes a spectrum of manifestations. The bacteria can spread through the bloodstream to the eye, or inflammation can arise indirectly via immune mechanisms. Manifestations vary by stage and individual immune response. Common presentations include anterior uveitis, posterior uveitis, chorioretinitis, retinitis, optic neuritis, and papillitis. Some forms are painless, while others cause significant pain and vision changes. Because ocular syphilis can mimic other diseases, a high index of clinical suspicion and targeted testing is important.
Uveitis and iritis
Anterior uveitis (iritis) and intermediate uveitis are well-documented forms of ocular syphilis. They can cause redness, photophobia, blurred vision, and floating spots. Iritis typically involves inflammation of the iris; anterior uveitis may also involve the ciliary body. These forms often respond well to antibiotics and, in some cases, short-term corticosteroids to control inflammation. Without treatment, they may lead to complications such as syphilitic keratitis or band keratopathy in chronic cases.
Chorioretinitis and retinitis
Posterior segment involvement, including chorioretinitis and retinitis, can occur in both early and late syphilis. Patients may experience floaters, decreased vision, or scotomas. Lesions are often multifocal and can be associated with vasculitis. Imaging and careful ophthalmologic evaluation help distinguish syphilitic retinitis from other infectious or inflammatory conditions. With appropriate therapy, retinitis can stabilize, though pre-existing structural damage may cause permanent visual field defects.
Optic nerve involvement
Optic neuritis or papillitis related to syphilis may present with pain on eye movement, relative afferent pupillary defect, and visual acuity loss. Because these symptoms overlap with other optic neuropathies, a thorough neuro-ophthalmic assessment is essential. When syphilis is suspected as the cause, serologic testing and imaging support diagnosis, and prompt treatment can prevent further vision loss.
Symptoms to watch for
Eye-related symptoms of syphilis are diverse. They can develop at any stage and sometimes precede other recognized signs of infection. Common ocular signs and symptoms include:
- Redness or conjunctival injection
- Eye pain or tenderness
- Photophobia (light sensitivity)
- Blurred or decreased vision
- Floaters or spots in the visual field
- Vision loss or visual field cut
Systemic features such as rash, mucocutaneous lesions, fever, or lymphadenopathy may accompany ocular symptoms in secondary syphilis. However, ocular disease can also occur without obvious systemic signs, especially in latent or tertiary stages.
Risk factors and transmission
Syphilis is primarily transmitted through direct contact with infectious lesions, typically during vaginal, anal, or oral sex. Ocular involvement is not tied to a specific route of transmission but is more likely in individuals with untreated or late-stage infection. Risk factors include multiple sexual partners, lack of consistent condom use, and coinfection with other sexually transmitted infections. People who are immunocompromised may be at higher risk of severe or atypical ocular disease.
Diagnosis of ocular syphilis
Diagnosis begins with a high clinical suspicion, supported by detailed history and comprehensive eye examination. Key steps in evaluation include:
- Detailed medical and sexual history
- Full slit-lamp and dilated fundus examination
- Intraocular pressure measurement
- Visual acuity, visual field, and color testing
- Opt coherence tomography and fluorescein angiography when indicated
Laboratory confirmation typically involves nontreponemal tests (e.g., RPR or VDRL) and treponemal tests (e.g., TP-PA, FTA-ABS, or EIA/CIA). Cerebrospinal fluid analysis may be considered if neurosyphilis is suspected. Imaging, such as optical coherence tomography, can support diagnosis and monitor treatment response.
Serologic testing integration
Serologic testing is central to diagnosing ocular syphilis. A positive treponemal test along with a reactive nontreponemal titer supports active infection. In some cases, serologic tests may be negative early in infection or during late latent disease, so results must be interpreted in context with clinical findings. Repeat testing over time can help clarify serologic status. Coordination with primary care or infectious disease specialists ensures comprehensive management.
Treatment approaches
The mainstay of treatment for ocular syphilis is appropriate antimicrobial therapy. The standard regimen depends on disease stage, severity, and neurologic involvement. Common approaches include:
| Disease stage or context | Recommended treatment | Key notes |
|---|---|---|
| Early syphilis (including ocular involvement) without neurologic signs | Benzathine penicillin G 2.4 million units intramuscularly once weekly for 1–2 weeks | Doxycycline or tetracycline are alternatives for penicillin-allergic patients |
| Late latent or tertiary syphilis | Benzathine penicillin G 2.4 million units intramuscularly once weekly for 3 weeks | Prolonged course to address persistent infection |
| Neurosyphilis or suspected ocular involvement with CNS concern | Aqueous crystalline penicillin G 18–24 million units daily via continuous infusion for 10–14 days | Hospitalization often recommended; follow with cerebrospinal fluid evaluation |
| Intermediate or posterior uveitis refractory to initial therapy | Same regimens as above, with possible short-course corticosteroids | Corticosteroids are adjunctive and not first line; used to control inflammation |
Patients should be monitored closely during and after treatment with repeat ophthalmologic examinations and serologic testing. Visual recovery varies; some degree of permanent visual impairment may remain if structural damage occurred before treatment.
Prognosis and follow-up
With timely diagnosis and adequate treatment, many forms of ocular syphilis can stabilize or improve. However, permanent vision loss is possible if diagnosis or treatment is delayed. Long-term follow-up includes repeated serologic testing to assess treatment response and monitoring for reinfection. Coordination among infectious disease, ophthalmology, and primary care supports comprehensive care and reduces the risk of complications.
When to seek care
People with known or suspected syphilis who notice eye redness, pain, blurred vision, floaters, or vision loss should seek prompt medical attention. Early intervention improves outcomes and reduces the risk of irreversible damage. Any new or worsening ocular symptoms during or after treatment warrant urgent evaluation by an eye care professional.
Conclusion
Syphilis can affect the eyes in multiple ways, including uveitis, chorioretinitis, retinitis, and optic nerve inflammation. Ocular syphilis may occur at any stage and can be painless or vision-threatening. Diagnosis relies on clinical judgment, serologic testing, and specialized eye exams. Treatment with antibiotics, often penicillin, and careful monitoring can preserve vision. Awareness of ocular symptoms and timely care are essential for minimizing long-term visual consequences.